These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37524284)

  • 1. Small-diameter PCL/PU vascular graft modified with heparin-aspirin compound for preventing the occurrence of acute thrombosis.
    Zhou SY; Li L; Xie E; Li MX; Cao JH; Yang XB; Wu DY
    Int J Biol Macromol; 2023 Sep; 249():126058. PubMed ID: 37524284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Patency and Endothelialization of Small-Caliber Vascular Grafts Fabricated by Coimmobilization of Heparin and Cell-Adhesive Peptides.
    Choi WS; Joung YK; Lee Y; Bae JW; Park HK; Park YH; Park JC; Park KD
    ACS Appl Mater Interfaces; 2016 Feb; 8(7):4336-46. PubMed ID: 26824876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for preventing thrombosis in solid organ transplant recipients.
    Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin.
    Merhi Y; Bernier J; Marois Y; Guidoin R
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):1-5. PubMed ID: 7564348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis.
    Makkar RR; Litvack F; Eigler NL; Nakamura M; Ivey PA; Forrester JS; Shah PK; Jordan RE; Kaul S
    Circulation; 1997 Feb; 95(4):1015-21. PubMed ID: 9054765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin immobilization reduces thrombogenicity of small-caliber expanded polytetrafluoroethylene grafts.
    Heyligers JM; Verhagen HJ; Rotmans JI; Weeterings C; de Groot PG; Moll FL; Lisman T
    J Vasc Surg; 2006 Mar; 43(3):587-91. PubMed ID: 16520178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sustained heparin release from PCL/chitosan hybrid small-diameter vascular grafts on anti-thrombogenic property and endothelialization.
    Yao Y; Wang J; Cui Y; Xu R; Wang Z; Zhang J; Wang K; Li Y; Zhao Q; Kong D
    Acta Biomater; 2014 Jun; 10(6):2739-49. PubMed ID: 24602806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid endothelialization and controlled smooth muscle regeneration by electrospun heparin-loaded polycaprolactone/gelatin hybrid vascular grafts.
    Shi J; Chen S; Wang L; Zhang X; Gao J; Jiang L; Tang D; Zhang L; Midgley A; Kong D; Wang S
    J Biomed Mater Res B Appl Biomater; 2019 Aug; 107(6):2040-2049. PubMed ID: 30556953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent grafting of PEG and heparin improves biological performance of electrospun vascular grafts for carotid artery replacement.
    Zhu T; Gu H; Zhang H; Wang H; Xia H; Mo X; Wu J
    Acta Biomater; 2021 Jan; 119():211-224. PubMed ID: 33181359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of patency rate in heparin-coated small synthetic vascular grafts.
    Walpoth BH; Rogulenko R; Tikhvinskaia E; Gogolewski S; Schaffner T; Hess OM; Althaus U
    Circulation; 1998 Nov; 98(19 Suppl):II319-23; discussion II324. PubMed ID: 9852921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the inflammatory response by vascular grafts modified with Aspirin-Triggered Resolvin D1 promotes blood vessel regeneration.
    Shi J; Zhang X; Jiang L; Zhang L; Dong Y; Midgley AC; Kong D; Wang S
    Acta Biomater; 2019 Oct; 97():360-373. PubMed ID: 31351251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
    Torsney E; Mayr U; Zou Y; Thompson WD; Hu Y; Xu Q
    Circ Res; 2004 Jun; 94(11):1466-73. PubMed ID: 15117816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physico-mechanical and biological evaluation of heparin/VEGF-loaded electrospun polycaprolactone/decellularized rat aorta extracellular matrix for small-diameter vascular grafts.
    Cuenca JP; Kang HJ; Fahad MAA; Park M; Choi M; Lee HY; Lee BT
    J Biomater Sci Polym Ed; 2022 Sep; 33(13):1664-1684. PubMed ID: 35446751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
    Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Evaluation of Gamma-Irradiated and Heparin-Immobilized Small-Diameter Polycaprolactone Vascular Grafts with VEGF in Aged Rats.
    Kim SE; Jeong SI; Shim KM; Jang K; Park JS; Lim YM; Kang SS
    Polymers (Basel); 2022 Mar; 14(6):. PubMed ID: 35335595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J; Xue L; Husak VA; Ellinger J; Greisler HP
    Am J Surg; 2003 Nov; 186(5):556-60. PubMed ID: 14599625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-bonded grafts induce platelet aggregation in the presence of heparin-associated antiplatelet antibodies.
    Almeida JI; Liem TK; Silver D
    J Vasc Surg; 1998 May; 27(5):896-900; discussion 900-1. PubMed ID: 9620142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term anticoagulation and selective cells adhesion surface via combination of covalent grafting and layer by layer assembly.
    Li C; Mao J; Li Q; Wang F; Jiao Y; Zhang Z; Guidoin R; Wang L
    Biomed Mater; 2019 Oct; 14(6):065012. PubMed ID: 31530752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heparin-bonded vascular graft generates no systemic effect on markers of hemostasis activation or detectable heparin-induced thrombocytopenia-associated antibodies in humans.
    Heyligers JM; Lisman T; Verhagen HJ; Weeterings C; de Groot PG; Moll FL
    J Vasc Surg; 2008 Feb; 47(2):324-9; discussion 329. PubMed ID: 18241756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery.
    Dörffler-Melly J; Büller HR; Koopman MM; Prins MH
    Cochrane Database Syst Rev; 2003; (4):CD000536. PubMed ID: 14583924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.